Ads
related to: sarcoma
Search results
Targeting glutamine metabolism improves sarcoma response to radiation therapy in vivo -...
Nature· 2 days agoUsing primary mouse model of soft-tissue sarcoma (STS), authors show that sarcoma switches to glutamine metabolism post radiation therapy, and inhibition ...
Signs and Symptoms of Vulvar Cancer
Health via Yahoo News· 7 days agoThey can appear in different shapes and may have uneven coloring. Later signs of vulvar melanoma may include pain, itching, genital bleeding, or a lump...
Earnings call: Adaptimmune outlines afami-cel launch and financials By Investing.com
Investing.com· 7 days agoAdaptimmune Therapeutics PLC (NASDAQ:ADAP), a biotechnology company specializing in T-cell therapy,...
Anti-inflammatory diet guide: Foods, benefits and meal plan
The Telegraph via Yahoo News· 2 days agoIgnore chronic inflammation at your peril. Recognised as a contributor to many deaths globally, half...
Middletown grads excited for future, cherish memories from last four years
The Frederick News-Post, Md. via Yahoo News· 9 hours agoMadisyn Ledder was worried she wasn't going to graduate on time with the rest of her peers from Middletown High School this year. During Middletown High's graduation ceremony on Tuesday afternoon ...
'I was looking at my child, planning his funeral': The horror of the infected blood scandal, by the...
Daily Telegraph· 3 days agoThe infected blood scandal can only be described as a catalogue of heartbreak. More than 30,000...
Q1 2024 TRACON Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 days agoWe plan to approach the FDA to discuss a BLA filing strategy if we determine nine responses by independent central review. As a reminder, we have received fast-track designation for enva in ...
HC Wainwright Reaffirms Buy Rating for BioAtla (NASDAQ:BCAB)
ETF DAILY NEWS· 4 days agoHC Wainwright restated their buy rating on shares of BioAtla (NASDAQ:BCAB – Free Report) in a research report released on Wednesday, Benzinga reports. They currently have a $7.00 price target ...
Adaptimmune secures $125 million loan for cancer therapy By Investing.com
Investing.com· 7 days ago(NYSE: NYSE:HTGC). The agreement, revealed on Wednesday, is poised to bolster Adaptimmune's...
Moleculin begins NIH-funded Phase II glioblastoma treatment trial
Clinical Trials Arena via Yahoo Finance· 6 days agoIn November last year, Moleculin reported positive initial efficacy data from the Phase II part of a...